In line with the latest report that vaccine for Zika virus is already patented, one cannot ignore the question whether the pharmaceutical company knew that Zika virus will become a global pandemic.
Bharat Biotech International in Hyderabad, India was the first company to file a patent for a Zika vaccine and they are about to start pre-clinical testing.
The company say that two candidate vaccines were created following research that began nine months ago and if trials are successful a vaccine could become available to the public in as little as four months.
They will now be tested in animal and human trials. If those trials are successful, a vaccine could become available to the public in around four months. The best case scenario is that the biotech firm could make one million doses in that time.
Research into the vaccines began after the biotech firm legally imported a live Zika virus into the country last year. Ella has sought direct intervention from Prime Minister Narendra Modi since then, urging for the vaccines to be fast-tracked through clinical trials.